Samsung Biologics
   HOME

TheInfoList



OR:

Samsung Biologics is a South Korean
biotechnology Biotechnology is the integration of natural sciences and engineering sciences in order to achieve the application of organisms, cells, parts thereof and molecular analogues for products and services. The term ''biotechnology'' was first used ...
company headquartered in Songdo, Incheon, South Korea. The biotech division of
Samsung Group The Samsung Group (or simply Samsung) ( ko, 삼성 ) is a South Korean multinational manufacturing conglomerate headquartered in Samsung Town, Seoul, South Korea. It comprises numerous affiliated businesses, most of them united under the ' ...
, it provides contract development and manufacturing (CDMO) services to the biopharmaceutical industry. The company has partnered with GlaxoSmithKline,
Eli Lilly Eli Lilly (July 8, 1838 – June 6, 1898) was an American soldier, pharmacist, chemist, and businessman who founded the Eli Lilly and Company pharmaceutical corporation. Lilly enlisted in the Union Army during the American Civil War and ...
and
AstraZeneca AstraZeneca plc () is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas includi ...
for COVID-19 treatments. Samsung Biologics also partnered with
Moderna Moderna, Inc. ( ) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to pro ...
for fill-finish, packaging and labeling of its
mRNA vaccine An mRNA vaccine is a type of vaccine that uses a copy of a molecule called messenger RNA (mRNA) to produce an immune response. The vaccine delivers molecules of antigen-encoding mRNA into immune cells, which use the designed mRNA as a blueprin ...
, Spikevax, and Greenlight Biosciences on the manufacturing of mRNA vaccine drug substance candidate during the
COVID-19 pandemic The COVID-19 pandemic, also known as the coronavirus pandemic, is an ongoing global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The novel virus was first identi ...
.


History

Founded in 2011, Samsung Biologics built three manufacturing plants with a capacity of more than 360,000 liters, from 2011 to 2018, making it the world's largest contract-based manufacturer in the biopharmaceutical sector at a single site as of 2018. Since 2020, Samsung Biologics has operated a research and development center in
San Francisco, California San Francisco (; Spanish for " Saint Francis"), officially the City and County of San Francisco, is the commercial, financial, and cultural center of Northern California. The city proper is the fourth most populous in California and 17th ...
. In 2012, it established Samsung Bioepis, a biosimilar medicine producer, with
Biogen Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. History ...
. The company acquired full ownership of Samsung Bioepis in 2022 by purchasing all remaining shares from Biogen for $2.3 billion. In November 2019, Samsung Biologics became the first contract manufacturing organization to obtain ISO 27001 certification and the first in the Korean biopharma industry to obtain an ISO 22301 certification in May 2020. In 2020, Samsung Biologics introduced S-CHOice, a cell line expression technology, and S-Cellerate to shorten the period for developing drugs the next year. The company also obtained ISO 45001, 50001, 14001 and 9001 in May 2021. Samsung Biologics published its first annual sustainability report in June 2021. The company also joined the Frontier 1.5D initiative, which works to limit the temperature rise within 1.5 degrees from pre-industrial times. It was added to the Dow Jones Sustainability World Index later that year.


References

{{KRX 100 companies Biopharmaceutical companies Samsung Companies based in Incheon Companies listed on the Korea Exchange